98%
921
2 minutes
20
Absolute quantification of target nucleic acids is essential for life analysis and can be achieved through droplet digital microfluidic nucleic acid quantification (droplet digital NAQ). Recent advancements in this field have incorporated polymers into droplets to form microgel particles, which add new functionalities to the droplets and offer opportunities for tandem analysis. However, the range of materials available for microgel-based droplet digital NAQ remains limited. In this study, we introduce acryloyl gelatin (GelA) as an additive polymer for droplet digital NAQ. GelA is photopolymerizable, biocompatible, and biodegradable, making it an ideal candidate for droplet digital NAQ applications. Our findings demonstrate that GelA exhibits minimal thermal variation in viscosity, which is favorable for droplet microfluidic production and handling. Additionally, GelA does not significantly affect the efficiency of droplet digital loop-mediated amplification (droplet digital LAMP) under the optimized conditions. Upon the addition of GelA, the droplet digital LAMP assay for the detection of the N gene in SARS-CoV-2 can be realized within the range of 25 to 250,000 copies/test, and the amplification is completed within 30 min. Following droplet digital LAMP, GelA droplets can be transformed into either physical or chemical microgel particles. In the microgel form, the particles are stable through transfer cycles, can prevent leakage of amplification products, and can facilitate controlled release of the products for further applications. This work broadens the range of materials available for droplet-based digital nucleic acid detection, increases the versatility of droplet digital LAMP, and opens new possibilities for advancements in this field.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.analchem.5c02761 | DOI Listing |
Front Immunol
September 2025
Division of Rheumatology, Department of Medicine, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Background: Regulatory T cells (Tregs) are found to be critical for maintaining immune tolerance to self-antigens; however, their status in primary Sjögren's syndrome (pSS) remains unclear. We investigated alterations in the abundance of peripheral Tregs in a large pSS cohort and their implications for patients.
Methods: Levels of CD4+CD25+FOXP3+Treg cells in the peripheral blood of 624 patients with pSS, and 93 healthy controls (HCs) were detected using modified flow cytometry (FCM).
Pract Lab Med
September 2025
Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
Background: Nucleic Acid Amplification Tests (NAAT) remain one of the most reliable methods for pathogen identification. Given the high false-negative rates associated with traditional staining and microscopic examination, the time-consuming nature and low sensitivity of bacterial culture methods, as well as the inability of conventional NAAT to achieve absolute quantification.
Methods: To achieve rapid and quantitative detection of , we selected the 23S rRNA gene as the target for identification and developed a droplet digital PCR detection method.
Clin Transplant Res
September 2025
Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Donor-derived cell-free DNA (dd-cfDNA) has emerged as a valuable noninvasive biomarker for detecting allograft injury in solid organ transplantation. It is released into the bloodstream from the transplanted organ as a result of cell injury and immune activation, with baseline levels influenced by organ type, tissue turnover, and posttransplant physiological changes. Several analytical platforms are available, including quantitative polymerase chain reaction (PCR), digital droplet PCR, and next-generation sequencing, each differing in sensitivity, throughput, and reporting format.
View Article and Find Full Text PDFSmall Methods
September 2025
Department of Pathology, College of Medicine, Hanyang University, Seoul, Republic of Korea.
While human epidermal growth factor receptor (HER2) has emerged as a tumor-agnostic biomarker, standard HER2 testing for anti-HER2 therapies using immunohistochemistry (IHC) and in situ hybridization (ISH) assays remains subjective, time-consuming, and often inaccurate. To address these limitations, an ultrafast and precise HER2 testing method is developed using Lab-On-An-Array (LOAA) digital real-time PCR (drPCR), a fully automated digital PCR enabling real-time absolute quantification. A multicenter study involving four independent breast cancer cohorts cross-validates the high diagnostic accuracy of drPCR-based HER2 assessment.
View Article and Find Full Text PDFClin Chim Acta
September 2025
Department of Hematology and Blood Banking, School of Allied Medical Sciences, Iran University of Medical, Tehran, Iran. Electronic address:
Acute myeloid leukemia (AML) represents a genetically heterogeneous malignancy, with mutations in the nucleophosmin-1 (NPM1) gene identified as the most prevalent and clinically significant molecular biomarkers. These mutations play a crucial pivotal role in the realms of diagnosis, prognosis, and therapeutic decision-making. Although an ideal measurable residual disease (MRD) test has yet to be developed, there is increasing acknowledgment of the significance of advanced molecular methodologies for monitoring MRD in NPM1-mutated (NPM1) AML.
View Article and Find Full Text PDF